Search result for 'shingrix'

GlaxoSmithKline Pharmaceuticals reports a 16% jump in Q2 net profit to Rs 252 crore, driven by strong sales across segments. Key brands like Augmentin and Nucala saw growth.

GlaxoSmithKline Pharmaceuticals (GSK Pharma) reported a 38% rise in Q1 net profit to Rs 182.33 crore, driven by strong growth in key brands and vaccines.

GlaxoSmithKline Pharmaceuticals's net profit fell 72% to Rs 46 crore in Q3, while revenue increased to Rs 833 crore. The company is focusing on new categories like adult immunisation.